These data show that IL-22 may affect atheroma development and instability because the activation of the signal transducer and activator of transcription 3 (STAT3) protein is directly related to leukocyte activation, the progression of endothelial dysfunction, and an intensified inflammatory cascade [13]. Here, STAT3 is linked to endothelial dysfunction.